Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Non-Current Assets (2020 - 2025)

BioAtla (BCAB) has disclosed Non-Current Assets for 6 consecutive years, with $5.8 million as the latest value for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 388.66% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $19.3 million, up 148.48%, while the annual FY2025 figure was $5.8 million, 388.66% up from the prior year.
  • Non-Current Assets hit $5.8 million in Q4 2025 for BioAtla, down from $6.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $7.1 million in Q4 2021 and bottomed at $753000.0 in Q1 2025.
  • Average Non-Current Assets over 5 years is $4.4 million, with a median of $4.4 million recorded in 2021.
  • On a YoY basis, Non-Current Assets climbed as much as 388.66% in 2025 and fell as far as 72.84% in 2025.
  • BioAtla's Non-Current Assets stood at $7.1 million in 2021, then dropped by 25.6% to $5.3 million in 2022, then crashed by 38.7% to $3.3 million in 2023, then crashed by 63.41% to $1.2 million in 2024, then soared by 388.66% to $5.8 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $5.8 million, $6.2 million, and $6.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.